Skip to main content

Table 1 Baseline characteristics of all patients

From: Initial serum sodium concentration determines the decrease in sodium level after terlipressin administration in patients with liver cirrhosis

Characteristics

Value

Age

55.62 ± 11.16

Sex

 

 Male (%)

103 (81.1)

 Female (%)

24 (18.9)

Etiology of cirrhosis

 

 Alcoholics (%)

73 (57.5)

 Non-alcoholics (%)

54 (42.5)

Reasons of use

 

 Bleeding control

99 (78.0)

 Hepatorenal syndrome

28 (22.0)

Albumin infusion

 

 Yes

46 (36.2)

 No

81 (63.8)

Cumulative dose of Terlipressin (mg)

15.35 ± 4.43

Amount of hydration (L)

4.38 ± 2.07

Amount of sodium infused (mEq)

309.99 ± 277.55

Total bilirubin (mg/dL)

5.96 ± 7.49

Albumin (g/dL)

2.65 ± 0.49

Creatinine (mg/dL)

1.64 ± 1.52

Potassium (mmol/L)

4.51 ± 0.98

Hemoglobin (g/dL)

9.15 ± 2.37

*PT (0.8 ~ 1.2 *INR)

1.78 ± 0.62

*MELD score

19.16 ± 10.82

*MELD-Na

21.94 ± 17.48

Child-Pugh Score (6 ~ 18)

8.83 ± 2.32

Initial sodium (mmol/L)

134.04 ± 6.52

  1. *PT, Prothrombin time; INR, International normalized ratio; MELD, Model for end-stage liver disease.